{"filing":{"accession_number":"0001493152-26-028635","cik":"0001857030","ticker":"INCR","company_name":"Intercure Ltd.","form":"6-K","filing_date":"2026-06-15","report_date":null,"primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1857030/000149315226028635/form6-k.htm"},"events":[{"id":12284,"run_id":10849,"accession_number":"0001493152-26-028635","anchor_item_number":"EX-99.1","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"The exhibit announces the successful completion of the first tranche (50%) of InterCure's acquisition of Botanico Ltd., with issuance of 2,471,061 ordinary shares and contingent issuance of an additional 2,470,073 shares upon satisfaction of conditions. This is a material acquisition transaction that expands the company's portfolio with exclusive rights to U.S. cannabis genetics, premium brands, and advanced technologies, directly supporting the company's strategic vision.","company_name":"Intercure Ltd.","ticker":"INCR","filing_date":"2026-06-15","form":"6-K","submitted_at":null,"items":[{"id":9093,"accession_number":"0001493152-26-028635","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces the successful completion of the first tranche (50%) of InterCure's acquisition of Botanico Ltd., with issuance of 2,471,061 ordinary shares and contingent issuance of an additional 2,470,073 shares upon satisfaction of conditions. This is a material acquisition transaction that expands the company's portfolio with exclusive rights to U.S. cannabis genetics, premium brands, and advanced technologies, directly supporting the company's strategic vision.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:33:52.149659+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9093,"accession_number":"0001493152-26-028635","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces the successful completion of the first tranche (50%) of InterCure's acquisition of Botanico Ltd., with issuance of 2,471,061 ordinary shares and contingent issuance of an additional 2,470,073 shares upon satisfaction of conditions. This is a material acquisition transaction that expands the company's portfolio with exclusive rights to U.S. cannabis genetics, premium brands, and advanced technologies, directly supporting the company's strategic vision.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:33:52.149659+00:00","company_name":"Intercure Ltd.","ticker":"INCR","filing_date":"2026-06-15"}]}